140 related articles for article (PubMed ID: 2665050)
1. Review of the modes of action of colloidal bismuth subcitrate.
Hall DW
Scand J Gastroenterol Suppl; 1989; 157():3-6; discussion 21-2. PubMed ID: 2665050
[TBL] [Abstract][Full Text] [Related]
2. Gastric mucosa protection and prostaglandin E2 generation in rats by colloidal bismuth subcitrate (DE-NOL).
Hall DW; van den Hoven WE
Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):308-19. PubMed ID: 3473983
[TBL] [Abstract][Full Text] [Related]
3. Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
Wagstaff AJ; Benfield P; Monk JP
Drugs; 1988 Aug; 36(2):132-57. PubMed ID: 3053124
[TBL] [Abstract][Full Text] [Related]
4. The mode of action of colloidal bismuth subcitrate.
Lee SP
Scand J Gastroenterol Suppl; 1991; 185():1-6. PubMed ID: 1957120
[TBL] [Abstract][Full Text] [Related]
5. Gastric mucosa protective effects of colloidal bismuth subcitrate (DE-NOL).
Hall DW; van den Hoven WE
Int J Tissue React; 1987; 9(5):427-32. PubMed ID: 3478321
[TBL] [Abstract][Full Text] [Related]
6. Colloidal bismuth subcitrate causes sustained release of gastric mucosal prostaglandin E2.
Mertz-Nielsen A; Steenberg P; Neumark T; Bukhave K; Rask-Madsen J
Aliment Pharmacol Ther; 1991 Apr; 5(2):127-33. PubMed ID: 1888815
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor (EGF) in the gastroprotective and ulcer healing actions of colloidal bismuth subcitrate (De-Nol) in rats.
Konturek SJ; Dembinski A; Warzecha Z; Bielanski W; Brzozowski T; Drozdowicz D
Gut; 1988 Jul; 29(7):894-902. PubMed ID: 3260885
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial action of bismuth in relation to Campylobacter pyloridis colonization and gastritis.
Marshall BJ; Armstrong JA; Francis GJ; Nokes NT; Wee SH
Digestion; 1987; 37 Suppl 2():16-30. PubMed ID: 3622946
[TBL] [Abstract][Full Text] [Related]
9. Advances in the understanding of the mechanism of cytoprotective action by colloidal bismuth subcitrate.
Konturek SJ; Radecki T; Piastucki I; Drozdowicz D
Scand J Gastroenterol Suppl; 1986; 122():6-10. PubMed ID: 3465028
[TBL] [Abstract][Full Text] [Related]
10. Morphologic evaluation of gastric mucosal protection by colloidal bismuth subcitrate (De-Nol).
van den Hoven WE; Birtwhistle RD; Hall DW
Int J Tissue React; 1988; 10(5):297-304. PubMed ID: 3250943
[TBL] [Abstract][Full Text] [Related]
11. Protective properties of colloidal bismuth subcitrate on gastric mucosa.
Hall DW; van den Hoven WE
Scand J Gastroenterol Suppl; 1986; 122():11-3. PubMed ID: 3465026
[TBL] [Abstract][Full Text] [Related]
12. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
Rösch W
Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
[TBL] [Abstract][Full Text] [Related]
13. Colloidal bismuth subcitrate-induced changes on gastric mucosal hemodynamics in the rat: gastric mucosal blood flow after CBS treatment.
Eleftheriadis E; Kotzampassi K; Tzartinoglou E; Salem A; Aletras H
Gastroenterol Jpn; 1991 Jun; 26(3):283-6. PubMed ID: 1889688
[TBL] [Abstract][Full Text] [Related]
14. Recent experimental and clinical studies on the pharmacology of colloidal bismuth subcitrate.
Elder JB
Scand J Gastroenterol Suppl; 1986; 122():14-6. PubMed ID: 3535016
[TBL] [Abstract][Full Text] [Related]
15. The role of colloidal bismuth subcitrate in gastric ulcer and gastritis.
Tytgat GN; Rauws E; Langenberg W
Scand J Gastroenterol Suppl; 1986; 122():22-9. PubMed ID: 3535018
[TBL] [Abstract][Full Text] [Related]
16. Clinical indications and efficacy of colloidal bismuth subcitrate.
Lambert JR
Scand J Gastroenterol Suppl; 1991; 185():13-21. PubMed ID: 1957121
[TBL] [Abstract][Full Text] [Related]
17. Colloidal bismuth subcitrate (De-Nol) inhibits degradation of gastric mucus by Campylobacter pylori protease.
Sarosiek J; Bilski J; Murty VL; Slomiany A; Slomiany BL
Am J Gastroenterol; 1989 May; 84(5):506-10. PubMed ID: 2470250
[TBL] [Abstract][Full Text] [Related]
18. Protection against chemically-induced oxidative gastrointestinal tissue injury in rats by bismuth salts.
Bagchi D; Carryl OR; Tran MX; Bagchi M; Vuchetich PJ; Krohn RL; Ray SD; Mitra S; Stohs SJ
Dig Dis Sci; 1997 Sep; 42(9):1890-900. PubMed ID: 9331152
[TBL] [Abstract][Full Text] [Related]
19. Studies on the gastroprotective and ulcer-healing effects of colloidal bismuth subcitrate.
Konturek SJ; Radecki T; Piastucki I; Drozdowicz D
Digestion; 1987; 37 Suppl 2():8-15. PubMed ID: 3622948
[TBL] [Abstract][Full Text] [Related]
20. Colloidal bismuth subcitrate evokes adaptive cytoprotection in rat gastric mucosa.
Balint GA
Acta Med Hung; 1991; 48(3-4):197-201. PubMed ID: 1822857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
